DPP-4 degrades GLP-1 (7-36) into the non insulinotropic GLP-1 (9-36) (some studies suggest it may have weak insulinotropic activity)
Bhatt K, Bhagavathula M, Verma S, Timmins GS, Deretic VP, Ellner JJ, Salgame P
Weight loss medication may also be used by individuals with a BMI of 27 or higher with a weight-related condition such as type 2 diabetes or high blood pressure
Further research is necessary to better understand its mechanisms of action, biological effects, safety profile, and potential applications within biomedical science
In cells, it helps transport fatty acids into the mitochondria, where they can be burned for energy
Delta Sleep-Inducing Peptide Dosing Guide | Verdict DSIP holds a significant place in the realm of sleep research